HER2 Positive Breast Cancer — Pre Operative Trastuzumab in Operable Breast Cancer
Citation(s)
A Phase III Double Blind Randomized Placebo Controlled Study of Trastuzumab as Short Duration Preoperative Therapy in Patients With HER2-neu Positive Operable Breast Cancer